Mental Health
Anxiety, depression, ADHD, sleep, and evidence-based care.
Evidence-based content on metabolic health, chronic disease, and everyday health decisions — no fluff, no sensationalism.
Browse All GuidesCurated topic hubs — rotates weekly
Anxiety, depression, ADHD, sleep, and evidence-based care.
Weight, insulin resistance, GLP-1s, and cardiometabolic risk.
Aging biology, lifespan heritability, and longevity debates.
Outbreaks, vaccines, and practical infectious disease guidance.
Demand for peptide therapy is exploding in the U.S., but regulation is still trying to define what’s legal, safe, and real medicine.
Utah is piloting AI-driven prescription renewals for chronic medications. The idea could improve access and reduce friction, but it also raises important questions about safety, accountability, transparency, and the loss of clinical touchpoints.
Most GLP-1 patients stop within a year. Here's why adherence — not efficacy — is the defining challenge in metabolic therapy.
A new BMJ Medicine study suggests stopping GLP-1 drugs may quickly erase their cardiovascular benefits.
New hypertension guidelines are changing who gets treated. Here's what it means in 2026.
Recently updated health guides
A clear, evidence-based guide to Lyme disease — causes, symptoms, diagnosis, treatment, and long-term outcomes.
A guide to the range of diseases spread by ticks, how they differ, and what to do after a tick bite.
A clear, practical guide to common peptides — what they do, how they work, and how they differ.
The 2025 AHA/ACC guideline emphasizes prevention, early treatment, pregnancy care, and brain health in managing high blood pressure.
How alcohol affects cancer risk, heart health, and long-term disease prevention.
An overview of MOTS-c, a mitochondrial-derived peptide studied in metabolism and aging research, including evidence limitations, regulatory status, and safety considerations.
A medical overview of oxytocin covering its established obstetric uses, research into social and mental health applications, evidence limitations, and safety considerations.
A patient-facing reference guide to tirzepatide — a dual GIP/GLP-1 receptor agonist used for type 2 diabetes and weight management — covering its mechanism, approved uses, benefits, risks, and regulatory context.